Supply Agreements in the Life Sciences Tools & Services Industry
59 Contracts & Agreements
- ArcherDX, Inc. (2 contracts)
- CHAMPIONS ONCOLOGY, INC. (1)
- ChromaDex Corp. (21)
- CM Life Sciences II Inc. (3)
- Codex DNA, Inc. (1)
- CODEXIS INC (19)
- Cytek BioSciences, Inc. (1)
- EMMAUS LIFE SCIENCES, INC. (1)
- Illumina Inc (0)
- INTERNATIONAL ISOTOPES INC (1)
- MARAVAI LIFESCIENCES HOLDINGS, INC. (2)
- Personalis, Inc. (4)
- Quanterix Corp (2)
- Sotera Health Co (1)
- Second Amendment to Supply Agreement, dated April 11, 2023, between SomaLogic, Inc. and Agilent Technologies, Inc (CM Life Sciences II Inc., Filed With SEC on August 14, 2023)
- Amendment No. 3 to the Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals (CODEXIS INC, Filed With SEC on May 4, 2023)
- Eighth Amendment to Manufacturing and Supply Agreement, dated as of December 14, 2022, by and between ChromaDex Inc. and W.R. Grace & Co.-Conn (ChromaDex Corp., Filed With SEC on March 8, 2023)
- Amendment No. 2 to the Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals, effective as of February 1, 2023 (CODEXIS INC, Filed With SEC on February 27, 2023)
- Amendment No. 1 to the Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals, effective as of December 19, 2022 (CODEXIS INC, Filed With SEC on February 27, 2023)
- Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals, dated as of July 14, 2022 (CODEXIS INC, Filed With SEC on February 27, 2023)
- Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals (CODEXIS INC, Filed With SEC on November 4, 2022)
- Supply Agreement, dated August 15, 2017, between SomaLogic, Inc. and Global Life Sciences Solutions USA LLC, as amended by that certain First Amendment to Catalog Product Support... (CM Life Sciences II Inc., Filed With SEC on March 29, 2022)
- Supply Agreement, dated April 8, 2019, between SomaLogic, Inc. and Agilent Technologies, Inc., as amended by that certain First Amendment to Supply Agreement, dated October 1,... (CM Life Sciences II Inc., Filed With SEC on March 29, 2022)
- Supply Agreement, dated December 19, 2018, by and between ChromaDex, Inc. and Nestec Ltd. * v (ChromaDex Corp., Filed With SEC on March 14, 2022)
- Supply Agreement between the Registrant and Cytek (Wuxi) Biosciences Co., Ltd, a China subsidiary of Cytek Biosciences, Inc., and Coherent NA, Inc. dated August 25, 2021 (Cytek BioSciences, Inc., Filed With SEC on November 12, 2021)
- Amendment No. 5 to Sitagliptin Supply Agreement, effective as of July 1, 2021, by and between Codexis, Inc. and Merck Sharp & Dohme Corp (CODEXIS INC, Filed With SEC on November 5, 2021)
- Seventh Amendment to Manufacturing and Supply Agreement, dated as of August 2, 2021, by and between ChromaDex Inc. and W.R. Grace & Co.-Conn (ChromaDex Corp., Filed With SEC on November 3, 2021)
- Amendment No. 1, effective as of June 6, 2021, to the Supply Agreement, dated as of October 9, 2020, among TriLink Biotechnologies, LLC, Pfizer Inc. and BioNTech SE (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on September 3, 2021)
- Seventh Amendment to Manufacturing and Supply Agreement, dated as of August 2, 2021, by and between ChromaDex Inc. and W.R. Grace & Co.-Conn (ChromaDex Corp., Filed With SEC on August 3, 2021)
- Supply Agreement, dated October 26, 2015, between the Registrant and Integrated DNA Technologies, Inc., as amended (Codex DNA, Inc., Filed With SEC on May 28, 2021)
- Restated Supply Agreement, dated as of October 6, 2020, between Balchem Corporation and Sterigenics U.S., LLC, Sterigenics S. De R.L. De C.V., Sterigenics Costa Rica S.R.L. and... (Sotera Health Co, Filed With SEC on November 18, 2020)
- Supply Agreement, dated as of October 9, 2020, by and among Pfizer Inc., BioNTech SE and TriLink BioTechnologies, LLC (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on November 9, 2020)
- Sixth Amendment to Manufacturing and Supply Agreement, dated as of September 17, 2020, by and between ChromaDex Inc. and W.R. Grace & Co.-Conn (ChromaDex Corp., Filed With SEC on November 4, 2020)
- Fifth Amendment to Manufacturing and Supply Agreement, dated as of January 1, 2020, by and between ChromaDex Inc. and W.R. Grace & Co.-Conn (ChromaDex Corp., Filed With SEC on November 4, 2020)
- Fourth Amendment to Manufacturing and Supply Agreement, dated as of April 15, 2019, by and between ChromaDex Inc. and W.R. Grace & Co.-Conn (ChromaDex Corp., Filed With SEC on November 4, 2020)
- Third Amendment to Manufacturing and Supply Agreement, dated as of January 1, 2019, by and between ChromaDex, Inc. and W.R. Grace & Co.-Conn (ChromaDex Corp., Filed With SEC on November 4, 2020)
- Second Amendment to Manufacturing and Supply Agreement, dated as of January 1, 2018, by and between ChromaDex, Inc. and W.R. Grace & Co.-Conn (ChromaDex Corp., Filed With SEC on November 4, 2020)
- Amendment to Manufacturing and Supply Agreement, dated as of February 27, 2017, by and between ChromaDex, Inc. and W.R. Grace & Co.-Conn (ChromaDex Corp., Filed With SEC on November 4, 2020)
- Manufacturing and Supply Agreement, dated as of January 1, 2016, by and between ChromaDex, Inc. and W.R. Grace & Co.-Conn (ChromaDex Corp., Filed With SEC on November 4, 2020)
- Amendment No. 1 to Supply Agreement, dated December 20, 2016, between Registrant and QIAGEN, Inc (ArcherDX, Inc., Filed With SEC on June 5, 2020)
- Supply and Manufacturing Agreement, dated December 16, 2014, between Registrant and QIAGEN Inc (ArcherDX, Inc., Filed With SEC on June 5, 2020)
- Quotation for Supply of Genetic Analysis Products, by and between Illumina, Inc. and the Registrant, dated November 19, 2019 (Personalis, Inc., Filed With SEC on March 25, 2020)
- Quotation for Supply of Genetic Analysis Products No. 4192031, by and between Illumina, Inc. and the Registrant, dated March 1, 2019 (Personalis, Inc., Filed With SEC on May 23, 2019)
- Quotation for Supply of Genetic Analysis Products No. SQ-20190214CG102, by and between Illumina, Inc. and the Registrant, dated February 22, 2019 (Personalis, Inc., Filed With SEC on May 23, 2019)
- Quotation for Supply of Genetic Analysis Products No. 4079884, by and between Illumina, Inc. and the Registrant, dated March 21, 2017 (Personalis, Inc., Filed With SEC on May 23, 2019)
- Manufacturing and Supply Agreement, dated April 5, 2019, between International Isotopes Inc. and Progenics Pharmaceuticals, Inc (INTERNATIONAL ISOTOPES INC, Filed With SEC on May 15, 2019)
- Supply Agreement, dated December 19, 2018, by and between ChromaDex, Inc. and Nestec Ltd (ChromaDex Corp., Filed With SEC on March 7, 2019)
- First Amendment to Supply and Manufacturing Agreement, dated October 17, 2013, between the Registrant and STRATEC Biomedical AG (Quanterix Corp, Filed With SEC on November 9, 2017)
- Supply and Manufacturing Agreement, dated September 14, 2011, between the Registrant and STRATEC Biomedical AG (Quanterix Corp, Filed With SEC on November 9, 2017)
- AMENDMENT NO. 4 TO SITAGLIPTIN SUPPLY AGREEMENT (CODEXIS INC, Filed With SEC on November 8, 2016)
- SECOND AMENDMENT TO NIAGEN(R) SUPPLY AGREEMENT (ChromaDex Corp., Filed With SEC on May 12, 2016)
- FIRST AMENDMENT TO NIAGEN(R) SUPPLY AGREEMENT (ChromaDex Corp., Filed With SEC on May 12, 2016)
- ADDENDUM TO THE NIAGEN(TM) SUPPLY AGREEMENT BETWEEN 5LINX ENTERPRISES, INC. AND CHROMADEX, INC. (ChromaDex Corp., Filed With SEC on May 12, 2016)
- AMENDMENT TO SUPPLY AGREEMENT (ChromaDex Corp., Filed With SEC on May 12, 2016)